SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Nov 16, 2022
Document Date
Nov 14, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Lineage Cell Therapeutics, Inc.
Issuer
LINEAGE CELL THERAPEUTICS, INC.
Filer
HOWE JILL ANN